FDA Office of Legislative Affairs
This article was originally published in The Gray Sheet
Executive Summary
Acting Associate Commissioner Kay Holcombe is leaving the agency to serve as counsel to the House Energy and Commerce Committee. Holcombe starts her new job on March 15.